Breast cancer and spironolactone: an observational postmarketing study.
Pierre SabatierJacques AmarFrançois MontastrucVanessa RousseauLeila ChebaneBéatrice BouhanickJean-Louis MontastrucPublished in: European journal of clinical pharmacology (2019)
This study did not find evidence for breast cancer associated with spironolactone.
Keyphrases